Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swedish research supports human papillomavirus (HPV) screening:

This article was originally published in Clinica

Executive Summary

The case for human papillomavirus screening is strengthened by recent research from Sweden which shows that the carcinogenic virus can be found in most women who develop cervical cancer. Two-thirds of women who go on to develop cervical cancer have oncogenic HPV in smear samples up to seven years before detection, according to the researchers (Cancer V 77, pp 121-7). Only 11% of smears from women who did not develop cancer had evidence of carcinogenic HPV.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087397

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel